dc.contributor
Institut Català de la Salut
dc.contributor
[de la Cruz Conty ML] Fundacion de Investigacion Biomedica, Puerta de Hierro University Hospital of Majadahonda, Madrid, Spain. [Encinas Pardilla MB] Department of Gynecology and Obstetrics, Puerta de Hierro University Hospital of Majadahonda, Madrid, Spain. [Garcia Sanchez M] Department of Gynecology and Obstetrics, Quironsalud Malaga University Hospital, Malaga, Spain. [Gonzalez Rodriguez L] Department of Gynecology and Obstetrics, Alvaro Cunqueiro Hospital of Vigo, Pontevedra, Spain. [Muner-Hernando ML] Department of Gynecology and Obstetrics, La Paz University Hospital, Madrid, Spain. [Royuela Vicente A] IDIPHISA Biomedical Research Institute, Madrid, Spain. [Martinez Diago C] Departament de Ginecologia i Obstetricia, Hospital Universitari de Girona Dr. Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain
dc.contributor
Hospital Universitari de Girona Dr Josep Trueta
dc.contributor.author
de la Cruz, María Luisa
dc.contributor.author
Encinas Pardilla, Maria Begoña
dc.contributor.author
García Sánchez, Marta
dc.contributor.author
González Rodríguez, Laura
dc.contributor.author
Muner-Hernando, Marta Luisa
dc.contributor.author
Royuela Vicente, Ana
dc.contributor.author
Martínez Diago, Clara
dc.date.accessioned
2025-10-24T10:56:04Z
dc.date.available
2025-10-24T10:56:04Z
dc.date.issued
2022-01-27T11:37:15Z
dc.date.issued
2022-01-27T11:37:15Z
dc.date.issued
2021-01-08
dc.identifier
de la Cruz Conty ML, Encinas Pardilla MB, Garcia Sanchez M, Gonzalez Rodriguez L, Muner-Hernando ML, Royuela Vicente A, et al. Impact of Recommended Maternal Vaccination Programs on the Clinical Presentation of SARS-CoV-2 Infection: A Prospective Observational Study. Vaccines (Basel). 2021 Jan 8;9(1):31.
dc.identifier
https://hdl.handle.net/11351/6918
dc.identifier
10.3390/vaccines9010031
dc.identifier.uri
https://hdl.handle.net/11351/6918
dc.description.abstract
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Vacunes; Embaràs
dc.description.abstract
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Vacunas; Embarazo
dc.description.abstract
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Vaccines; Pregnancy
dc.description.abstract
The COVID-19 pandemic has raised questions about the possible cross immunity resulting from common vaccination programs and SARS-CoV-2 infection. Therefore, the Spanish Obstetric Emergency group performed a multicenter prospective study on the vaccination status of Influenza and Tdap (diphtheria, tetanus and pertussis vaccine boost administered in adulthood) in consecutive cases of SARS-CoV-2 infection in a pregnancy cohort, in order to assess its possible association with the clinical presentation and severity of symptoms of SARS-CoV-2 infection, as well as to determine the factors that may affect vaccination adherence. A total of 1150 SARS-CoV-2 positive pregnant women from 78 Spanish hospitals were analyzed: 183 had not received either vaccine, 23 had been vaccinated for Influenza only, 529 for Tdap only and 415 received both vaccines. No association was observed between the vaccination status and the clinical presentation of SARS-CoV-2 infection and/or the severity of symptoms. However, a lower adherence to the administration of both vaccines was observed in the Latin-American subgroup. Based on the results above, we reinforce the importance of maternal vaccination programs in the actual pandemic. Health education campaigns should be specially targeted to groups less likely to participate in these programs, as well as for a future SARS-CoV-2 vaccination campaign.
dc.description.abstract
This research was supported by public funds obtained in competitive calls: Grant COV20/ 00021 from the Instituto de Salud Carlos III-Spanish Ministry of Health, and co-financed with Fondo Europeo de Desarrollo Regional (FEDER) funds.
dc.format
application/pdf
dc.format
application/pdf
dc.relation
Vaccines;9(1)
dc.relation
https://doi.org/10.3390/vaccines9010031
dc.rights
Attribution 4.0 International
dc.rights
https://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
COVID-19 (Malaltia) - Vacunació
dc.subject
DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections
dc.subject
PHENOMENA AND PROCESSES::Reproductive and Urinary Physiological Phenomena::Reproductive Physiological Phenomena::Reproduction::Pregnancy
dc.subject
CHEMICALS AND DRUGS::Complex Mixtures::Biological Products::Vaccines
dc.subject
ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus
dc.subject
FENÓMENOS Y PROCESOS::fenómenos fisiológicos reproductivos y urinarios::fenómenos fisiológicos de la reproducción::reproducción::embarazo
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::mezclas complejas::productos biológicos::vacunas
dc.title
Impact of Recommended Maternal Vaccination Programs on the Clinical Presentation of SARS-CoV-2 Infection: A Prospective Observational Study
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
